Tuesday, June 18, 2024
6:30 PM to 9:00 PM Eastern Time
Myeloma Rounds Philadelphia
Sheraton Philadelphia Downtown
Philadelphia Ballroom
201 North 17th Street
Philadelphia, PA 19103
Self-parking garage is located underneath the Sheraton.
*Healthcare professionals only: At the end of Rounds, upon submission of your completed program evaluation,
LLS will provide a voucher to cover your self-parking.
Agenda
6:30 PM – Dinner and Networking
7:00 PM – Welcome and Overview of Program
Edward Stadtmauer, MD
7:05 PM – Overview of LLS Resources
Amanda O'Neill, LMSW and Ruby Nava-Ramos, MPH
7:10 PM – Updates on Multiple Myeloma Clinical Trials in 2024
Adam Cohen, MD
7:25 PM– Case Presentation and Discussion on Early Line CAR-T in Multiple Myeloma
Asya Varshavsky-Yanovsky, MD, PhD and Daniel (Tuck) Stapor, MD
7:55 PM – Case Presentation and Discussion on MRD Testing in Newly Diagnosed Myeloma: Why, When, and for How Long?
Adam Binder, MD and Ian Landry, MD
8:25 PM – Case Presentation and Discussion on Recurrent AL Amyloidoma
Tulin Budak Alpdogan, MD and Ted Raddell, MD
8:55 PM – Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
Description
Live interactive continuing medical education activity for healthcare professionals in Philadelphia and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
Educational Objectives
After completing this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
-
Engage patients and caregivers in discussions on clinical trials, newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bispecific antibodies
-
Identify disparities and challenges in diagnosis and treatment of myeloma
-
Apply evidence-based treatment strategies for optimal patient care
-
Access patient support resources
Advisory Group
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Tulin Budak-Alpdogan, MD
Cooper University Health Care
Camden, NJ
Oxana Megherea, PharmD, BCOP
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Asya Varshavsky-Yanovsky, MD, PhD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Adam Waxman, MD, MS
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Faculty
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Tulin Budak-Alpdogan, MD
Cooper University Health Care
Camden, NJ
Adam Cohen, MD
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Ian Landry, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Ruby Nava-Ramos, MPH
The Leukemia & Lymphoma Society
Rye Brook, NY
Amanda O'Neill, LMSW
The Leukemia & Lymphoma Society
Rye Brook, NY
Ted Raddell, MD
Cooper University Health Care
Camden, NJ
Daniel (Tuck) Stapor, MD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Asya Varshavsky-Yanovsky, MD, PhD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc., in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: Profeducation@LLS.org.
